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Abstract: CRISPR-Cas9-based genome-editing is a highly efficient and cost-effective method to
generate zebrafish loss-of-function alleles. However, introducing patient-specific variants into the
zebrafish genome with CRISPR-Cas9 remains challenging. Targeting options can be limited by the
predetermined genetic context, and the efficiency of the homology-directed DNA repair pathway
is relatively low. Here, we illustrate our efficient approach to develop knock-in zebrafish models
using two previously variants associated with hereditary sensory deficits. We employ sgRNA-Cas9
ribonucleoprotein (RNP) complexes that are micro-injected into the first cell of fertilized zebrafish
eggs together with an asymmetric, single-stranded DNA template containing the variant of interest.
The introduction of knock-in events was confirmed by massive parallel sequencing of genomic DNA
extracted from a pool of injected embryos. Simultaneous morpholino-induced blocking of a key
component of the non-homologous end joining DNA repair pathway, Ku70, improved the knock-in
efficiency for one of the targets. Our use of RNP complexes provides an improved knock-in efficiency
as compared to previously published studies. Correct knock-in events were identified in 3–8% of
alleles, and 30–45% of injected animals had the target variant in their germline. The detailed technical
and procedural insights described here provide a valuable framework for the efficient development
of knock-in zebrafish models.
Keywords: zebrafish; CRISPR-Cas9; knock-in; homology-directed repair; disease models
1. Introduction
The use of CRISPR-Cas9-based genome editing to create loss-of-function alleles is
nowadays common practice in most model organisms. While the first reports employing
the CRISPR-Cas9 system to knock-in specific genetic variants by means of homology
directed repair (HDR) date back to 2013 [1,2], the overall efficiency of this application
remains much lower as compared to the generation of knock-out models. In zebrafish,
one of the easiest animal models to manipulate with CRISPR-Cas9, precise editing using
a template for HDR was first reported by Irion and colleagues in 2014 [3]. They used a
circular template vector containing 875 bp homology arms flanking the variant of interest,
which they co-injected with Cas9 mRNA and in-vitro synthesized sgRNA molecules to
repair the albino mutation (alb allele). More recent publications report on the use of
short (50–136 nt), single stranded oligonucleotide templates for HDR [4–6]. The use of
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oligonucleotide templates is advantageous compared to the use of vector templates with
long homology arms, as these oligonucleotide templates can be ordered commercially.
While the CRISPR-Cas9 system offers great potential for the introduction of specific genetic
mutations in the zebrafish genome, there are still only few studies that employ this strategy
to model the functional effects of human disease-associated genetic variants in zebrafish.
As a consequence of the implementation of next generation sequencing technologies—
such as whole exome sequencing and whole genome sequencing—the number of variants
of unknown significance (VUS), identified in genome diagnostics laboratories around the
globe, is rapidly growing. For genes with a high sequence conservation, the zebrafish can
offer an attractive model to assess the functional effects of VUS. The work of Tessadori et al.,
who used 50-mer symmetrical oligonucleotide templates, is a good example of modeling
genetic variants orthologous to those associated with human disease in zebrafish. The
percentage of animals in which the variant was introduced in the germline was found to
range between 4% and 21% [5]. While the identification of founder fish in 21% of injected
embryos sounds promising, they reported that the chance of success largely relies on the
initial efficiency of the ribonucleoproteins (RNPs) to induce DNA cleavage, and of RNPs
to cleave in close proximity to the target variant. A strong inverse relationship between
knock-in efficiency and the distance of the modification to the Cas9 cut site has indeed
been reported [7,8]. A recent publication showed that the generation of CRISPR-Cas9-
mediated knock-in zebrafish models could be significantly improved by the use of antisense
asymmetric oligonucleotides with homology arms of 36 and 90 nucleotides [4]. The 36-nt
arm of the oligonucleotide is thought to hybridize with the non-target strand of the target
gene, which becomes available upon binding of the Cas9-gRNA RNP complex to the target
strand, and thereby facilitates homology-directed repair [9].
Introducing variants associated with genetic disorders does not always leave room to
comply with the parameters for an optimal design. For example, directing Cas9 to cleave in
close proximity of the target variant relies on the availability of a Cas9-specific protospacer-
adjacent motif (PAM site). While variants of Cas9 with different PAM requirements are
rapidly emerging, they are not yet commercially available as recombinant proteins to
use in Cas9-gRNA RNP complex injections in zebrafish embryos. Techniques such as
base-editing and prime-editing are often seen as the solution to this problem [10,11].
However, the studies describing these techniques have prepared their own recombinant
proteins for microinjection, and/or are currently restricted to the injection of in-vitro
transcribed mRNA.
Another option to improve knock-in efficiency is to downregulate or block the non-
homologous end joining pathway (NHEJ) to effectively increase HDR-mediated DNA re-
pair upon nuclease activity. The NHEJ pathway is the primary DNA repair pathway in the
developing zebrafish embryo, with small insertions and deletions a result [12,13]. Downreg-
ulation of the NHEJ pathway has been reported in human cells [14], via small molecule in-
hibitors. We previously employed morpholino (PMO) antisense oligonucleotide-mediated
knockdown of Ku70, the protein that forms a complex with Ku80 to recruit NHEJ proteins
to broken DNA ends [13], to introduce a human pseudoexon into the zebrafish ush2a
gene [15]. After the successful introduction of the pseudoexon, we further optimized
our CRISPR-Cas9 protocols, and investigated the effect of Ku70 knockdown to enhance
knock-in efficiency in more detail.
Here, we present our efficient procedure to develop knock-in zebrafish models using
Cas9-gRNA RNP complexes and antisense asymmetric template oligos. We illustrate our
approach using two variants that were identified after genetic screening of patients with
hereditary sensory deficits. The first is the retinitis pigmentosa (RP) and Usher syndrome-
associated c.2276G>T (p.(Cys759Phe), NM_206933) variant in USH2A. The pathogenicity
of this variant has been under debate after it was identified in 2003 in homozygous state
in two individuals with normal visual function [16,17]. The second variant is a small
in-frame deletion in RIPOR2 (c.1696_1707del; p.(Gln566_Lys569del), NM_014722.3) that
we recently identified as a major cause of dominantly inherited hearing loss DFNA21 [18].
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We furthermore show how morpholino-based knockdown of Ku70 increased knock-in
efficiency for one of the targets. With somatic knock-in events in 3.4–18.0% of sequencing
reads, and germline transmission of the variants of interest in 30–45% of adult zebrafish,
our approach can provide a template for a more frequent use of zebrafish to model the
functional effects of genetic variants associated with human disorders. A detailed protocol
is provided in the supplemental data (Supplemental Document S1).
2. Results
2.1. sgRNA Design and Efficiency
The c.2276G>T variant in USH2A, leading to the substitution of a phenylalanine for cys-
teine at position 759 of the usherin protein, is orthologous to a c.2312G>T (p.(Cys771Phe))
substitution in zebrafish ush2a (Supplemental Figure S1A). For this variant, sgRNA design
was limited by the genetic context of the target site. The six top-ranked sgRNA target sites
predicted for Cas9 that are close to the variant of interest, and allow for the introduction
of a silent PAM-site-disrupting variant, are 19, 32, and 47 nt downstream, and 12, 29,
and 36 nt upstream of position c.2312. For an efficient introduction of the target variant,
the Cas9 cleavage site should be ideally at a distance <10 nt from the target site [8]. We
therefore decided to use a lower-ranked sgRNA that directs Cas9 to cleave between the
second and third nucleotide upstream of position c.2312, yet might display some off-target
cleavage activity. To improve in-vitro sgRNA transcription we introduced a C>G change at
the 5′ position of the target-specific sequence. The resulting sgRNA has three predicted
off-target sites with 1–2 nt mismatches and/or 1 nt bulge. We considered this situation
preferable over the use of a more specific sgRNA that would direct Cas9 to cleave further
away from position c.2312. The second variant, c.1777_1788del (p.(Gln593_Arg596del))
in ripor2, corresponds to the DFNA21-associated c.1696_1707del variant in the human
RIPOR2 gene (Supplemental Figure S1B). We identified a sgRNA that directs Cas9 to cleave
the DNA between nucleotides 8 and 9 of the 12 nucleotides that we aim to delete.
Prykhozhij et al. previously showed that antisense asymmetric HDR templates pro-
vide improved knock-in efficiency over sense symmetric oligos [4]. We therefore designed
asymmetric antisense HDR templates to introduce our variants of interest based on their
strategy. The ush2a C771F HDR template includes the c.2312 G>T substitution and a silent,
PAM-site disrupting C>T substitution at position c.2304 (Figure 1A). The ripor2 del12 HDR
template (shown in sense orientation) includes the c.1777_1788del variant and a silent,
PAM-site disrupting G>A substitution at position c.1790 (Figure 1B).
For both targets, we first investigated whether Cas9-sgRNA ribonucleoprotein (RNP)
complexes were efficient in generating lesions at the target site. For both targets we injected
the appropriate RNP complexes into the first cell of fertilized zebrafish embryos (zygote).
At 1 day post fertilization (dpf), we collected a subset of the injected embryos for genetic
analysis (n = 7). To rapidly detect the presence of genomic lesions in the embryos, we ex-
tracted DNA from individual RNP-injected and uninjected embryos, and amplified a small
region flanking the sgRNA target site using a nucleic acid dye-supplemented PCR. We sub-
sequently performed high-resolution melting (HRM) analyses of the amplicons to rapidly
visualize genome-editing events [19]. For both ush2a (Figure 1C) and ripor2 (Figure 1D),
HRM analysis of uninjected embryos revealed a single peak that corresponds with the
presence of wildtype amplicons. HRM analysis of ush2a RNP-injected embryos resulted in
the typical double peak signature of CRISPR-Cas9-induced genomic lesions (Figure 1C).
The nature of both mutant and wildtype amplicons was verified using Sanger sequencing
(Figure 1C, right panel). The typical overlapping sequence traces following the Cas9 cleav-
age site indicate the presence of multiple somatic mutations within the embryo. The ripor2
RNP-injected embryos did not display the typical double peaks on HRM analysis, but
rather a single peak with a heightened left shoulder. Sanger sequence revealed that also this
pattern corresponds to the presence of multiple somatic mutations (Figure 1D, right panel).
The double peaks are observed relatively far upstream from the Cas9 cleavage site (which
cannot be identified in the sequencing traces). However, the 5′ boundary does not match
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that the intended deletion indicating that different deletions are formed upon injection of
the ripor2 RNP complex. For both RNPs, we observed genome-editing events in 100% of
injected embryos.




Figure 1. Study design and validation of sgRNA-Cas9 ribonucleoprotein complex efficiency. (A) Graphic representation 
of the target region in ush2a exon 13. The sgRNA (targeting the complementary strand) and protospacer-adjacent motif 
(PAM) are indicated and allow for Cas9 cleavage in close proximity of position c.2312. The asymmetric antisense template 
for homology directed repair contains the c.2312G>T variant and a silent PAM-site change. (B) Graphic representation of 
the target region in ripor2 exon 14. The sgRNA is designed to direct Cas9 to cleave within the nucleotide sequence that we 
aimed to delete. The asymmetric antisense template for homology directed repair, containing the 12-nucleotide deletion 
and a silent PAM-site change, is shown in sense orientation. (C) High resolution melting (HRM) analysis profiles of 
individual embryos injected with the ush2a sgRNA-Cas9 ribonucleoprotein (RNP) complex. A representative example of 
the Sanger sequencing traces from a single embryo is shown on the right. The typical overlapping peaks occur around the 
indicated Cas9 cleavage site. (D) HRM analysis profiles of individual ripor2 sgRNA-Cas9 ribonucleoprotein (RNP) 
complex injected embryos. The typical overlapping peaks in the sanger sequencing traces, shown on the right, are 
indicative of sgRNA-Cas9 RNP activity. 
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Figure 1. Study design and validation of sgRNA-Cas9 ribonucleoprotein complex efficiency. (A) Graphic representation
of the target region in ush2a exon 13. The sgRNA (targeting the complementary strand) and protospacer-adjacent motif
(PAM) are indicated and allow for Cas9 cleavage in close proximity of position c.2312. The asymmetric antisense template
for homology directed repair contains the c.2312G>T variant and a silent PAM-site change. (B) Graphic representation of
the target region in ripor2 exon 14. The sgRNA is designed to direct Cas9 to cleave within the nucleotide sequence that we
imed to delete. The asymmetric antisense templat for homology directed repair, c taining the 12-nucleotide deletion and
a silent PAM-site cha g , is shown in sense orientation. (C) High r solutio melting (HRM) analysis profiles of individual
embryos injected with the ush2a sgRNA-Cas9 rib nucle protein (RNP) complex. A representative example of the Sanger
sequencing traces from a single embryo is shown on the right. The typical overlapping peaks occur around the indicated
Cas9 cleavage site. (D) HRM analysis profiles of individual ripor2 sgRNA-Cas9 ribonucleoprotein (RNP) complex injected
embryos. The typical overlapping peaks in the sanger sequencing traces, shown on the right, are indicative of sgRNA-Cas9
RNP activity.
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2.2. Efficient Generation of Knock-In Alleles Using CRISPR-Cas9 RNPs and Asymmetric
Antisense HDR Templates
From the high on-target genome-editing efficiency, we concluded that both the ush2a
and ripor2 RNPs are likely suitable to knock-in the variants of interest. We next injected
the antisense asymmetric oligonucleotide templates together with the appropriate ush2a
or ripor2 RNPs into the zebrafish zygotes. To minimize the influence of differences be-
tween individual microinjections and batch-to-batch variation in egg quality, all injections
were done in 4–6 replicate injections, using wildtype zebrafish embryos from 3–5 dif-
ferent spawnings. As the introduction of the patient-specific variants does not create a
variant-specific restriction site, or allows for alternative low-cost means to assess knock-in
efficiency, we immediately proceeded with massive parallel sequencing to visualize poten-
tial knock-in events. Genomic DNA was extracted from pools of 20–25 injected zebrafish
embryos at 1 dpf, after which the knock-in target regions were amplified by PCR using
primers upstream and downstream from the HDR template, and subjected to Ion Torrent
sequencing. Since we aimed to introduce a nucleotide substation and 12-nt deletion, we
assumed that the amplification bias in the Ion Torrent sequencing results was negligible.
The Ion Torrent platform has a slightly higher error rate than the frequently used Illumina
sequencing platform [20], which we countered with a high sequencing depth for each
target (>50,000 reads obtained from the genomic DNA of each pool of embryos).
For ush2a, we observed 85.7 ± 8.6% of mutant (non-wildtype) reads after injection
of zygotes with sgRNA-Cas9 RNP complexes and HDR template (Figure 2A). This con-
firms the high genome-editing efficiency that we observed by individual HRM analyses
of embryos injected with ush2a sgRNA-Cas9 RNP complexes. We also observed high
genome-editing efficiency of the sgRNA-Cas9 RNPs in ripor2 knock-in injected embryos
(80.5 ± 24.7%; Figure 2A). The large standard deviation results from one injection in which
only 45% of the reads contained an indication for sgRNA-Cas9 RNP activity. To place our
obtained editing-efficiency into perspective, we also injected the sgRNA for tp53 R217H pre-
viously described by Prykhozhij et al. in their study to introduce the p.R217H variant using
the antisense asymmetric oligo templates for HDR in zebrafish [4]. Note that Prykhozhij
et al. made use of Cas9 mRNA, whereas we injected in vitro assembled sgRNA-Cas9 RNP
complexes. We observed 56.6 ± 1.7% (n = 2) of mutant tp53 reads (Figure 2A). In the study
of Prykhozhij et al., the delivery of sgRNAs with Cas9 mRNA resulted in only 28.4% of
reads in which genome-editing events were identified.
We defined successful knock-in reads as all reads that contain the variant of interest,
with or without PAM-site change, and do not contain any other insertions, deletions or
single nucleotide changes in the target region. Correct knock-in of the target variants was
found in 5.2 ± 1.4% of the reads from embryos injected with RNP complexes and template
to introduce the c.2312G>T (p.(Cys771Phe)) variant in ush2a (henceforth termed ush2a
C771F injected embryos), and 12.4 ± 5.8% of the reads from embryos injected with RNP
complexes and template to introduce the c.1777_1788del; p.(Gln593_Arg596del) variant
in ripor2 (ripor2 del12 injected embryos) (Figure 2B). The majority (>75%) of the correct
ush2a C771F knock-in reads also contained the PAM-site change. For ripor2 del12, a little
under half of the correct knock-in reads contained the PAM-site change. When expressed as
percentage of the total reads, 4.0 ± 1.3% (ush2a) and 5.7 ± 2.9% (ripor2) of reads displayed
both the correct knock-in of the variant and the PAM-site change. There were also many
other reads in which the target variant was identified, together with additional insertions,
deletions or nucleotide substitutions. These events occurred approximately 2–4 times
less frequently as compared to the correct knock-in events, and are collectively displayed
as knock-in events with indels (Figure 2B). Examples of the different types of reads are
provided in Figure 2C,D for respectively ush2a C771F and ripor2 del12. The reads including
the variant of interest together with an insertion, deletion, or nucleotide substitution, are
examples of erroneous genome-editing outcomes that were observed repeatedly within
the sequencing reads (>50,000 reads per target). We also performed this analysis for the
tp53 R217H injected embryos (two replicate injections), and identified correct knock-in
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events in 4.3 ± 0.8% of reads, and correct knock-in events including the PAM-site change
in 3.0 ± 0.6% of reads (Figure 2B). This percentage is slightly lower than that of ush2a
C771F injected embryos, and markedly lower than that of ripor2 del12 injected embryos.
However, the original publication on the knock in of the tp53 R217H variant using antisense
asymmetric oligonucleotide templates resulted in the correct knock-in of both variant and
PAM-site change in approximately 2% of sequencing reads.




Figure 2. Next-generation sequencing analysis of knock-in efficiency after sgRNA-Cas9 RNP and HDR template delivery. 
(A) Percentage of mutant reads in the genomic DNA of pooled embryos after injection of sgRNA, Cas9, and asymmetric 
antisense oligonucleotide templates. Mutant reads are quantified as the percentage of all non-wildtype reads. Data is 
expressed as mean (bar) and values of individual replicates (scatterplot). (B) Knock-in efficiency after injection of sgRNA, 
Cas9 and asymmetric antisense oligonucleotide template. Knock-in (KI) reads are quantified as percentage of total reads 
with correct knock-in with and without the silent variant in the protospacer adjacent motif (PAM). The percentage of 
correct knock-in reads with additional variants is provided as KI + indels. Examples of correct knock-in reads with and 
without PAM variants and indels are provided for (C) ush2a C771F RNP injected embryos, and (D) ripor2 del12 RNP 
injected embryos. The correctly-introduced nucleotide substitutions are indicated in red. Unintended nucleotide 
substitutions are indicated with a red font on orange background. Deletions are indicated in dark blue. The PAM sites are 
indicated on the wildtype sequences by a green box.  
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Figure 2. Next-generation sequencing analysis of knock-in efficiency after sgRNA-Cas9 RNP and
HDR template delivery. (A) Percentage of mutant reads in the genomic DNA of pooled embryos after
injection of sgRNA, Cas9, and asymmetric antisense oligonucleotide templates. Mutant reads are
quantifi d as the percentage of all non-wildtype reads. Data is expr ssed as mean (bar) and values
of individual replicates (scatterplot). (B) Knock-in efficiency after injection of sgRNA, Cas9 and
asymmetric antisense oligonucleotide template. Knock-in (KI) reads are quantified as percentage of
total reads with corr ct knock-in with and without the silent variant in the protospacer adjacent motif
(PAM). The percentage of correct knock-in reads with additional variants is provided as KI + indels.
Examples of correct knock-in reads with and without PAM variants and indels are provided for
(C) ush2a C771F RNP injected embryos, and (D) ripor2 del12 RNP injected emb yo . The corr ctly-
introduced nucleotide substitutions are indicated in red. Unintended nucleotide substitutions are
indicated with a red font on orange background. Deletions are indicated in dark blue. The PAM sites
are indicated on the wildtype sequences by a green box.
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The variant of interest in ripor2 is a 12-nucleotide deletion, which in theory can directly
result from RNP activity followed by non-homologous end-joining (NHEJ) DNA repair, as
CRISPR-Cas9 is known for the ability to introduce small insertions and deletions. However,
Sanger sequencing traces of the majority of ripor2 del12 RNP injected embryos indicate
that this is not the case as the typical overlapping peaks start 3 nucleotides upstream of the
intended 12-nt deletion (Figure 1D).
2.3. Knock-Down of the Non-Homologous End-Joining Pathway May Improve Knock-in Efficiency
We previously described the generation of a humanized zebrafish knock-in model for
the pathogenic deep-intronic c.7595-2144A>G variant in human USH2A, resulting in the
inclusion of a pseudo-exon (PE40). We applied a morpholino (PMO)-induced knock-down
of Ku70, a critical component of the NHEJ pathway encoded by the xrcc6 gene [13], to
presumably improve knock-in efficiency [15]. The knock-in of the pseudo-exon was only
observed upon co-injection of CRISPR-Cas9 components, template and the xrcc6-targeting
PMO, suggesting that the suppression of Ku70 expression had a positive effect on the
knock-in efficiency. As this positive effect was not quantified at the time, we investigated
the potential improvement in knock-in efficiency of the target variants in ush2a, ripor2, and
tp53 after Ku70 knockdown. The xrcc6-targeting PMO, delivered into fertilized zebrafish
cell together with the sgRNA-Cas9 RNP complexes, was previously titrated at 1.5 pg per
embryo [15]. For each replicate injection, one or multiple pools of 20–25 embryos were
sampled for genomic analysis of knock-in events at 1 dpf, and pools of 2 dpf embryos were
sampled to assess PMO-induced alternative splicing of xrcc6. Presence of alternatively-
spliced xrcc6 transcripts was confirmed for all replicate injections that were included in
this study. An example of the alternative xrcc6 splicing is shown Figure 3A. Injection of
the PMO-induced skipping of xrcc6 exon 2 or the (partial) retention of intron 2, as can be
observed in all three PMO-injected conditions, but not in uninjected controls. The three
major alternatively-spliced transcripts were sequence verified and all contain premature
translation termination codons. We next amplified the knock-in target regions from the
genomic DNA of the zebrafish embryos injected with RNP and HDR template, with or
without xrcc6-targeting PMO, and quantified the frequency of knock-in reads using ion
torrent sequencing. To allow the comparison of our results with previously published
studies, we quantified the percentage of correct knock-in reads that also included the
PAM variant.
To our surprise, addition of the xrcc6-targeting PMO to the injection mixture increased
the percentage of knock-in reads only for the ripor2 del12 variant (Figure 3B). Since we
observed a high variation in knock-in efficiency between the different replicate injections,
we also visualized the change in knock-in efficiency between injections with and without
PMO performed in the same clutch of eggs (Figure 3C). Three out of the four replicate
injections with the ripor2 del12 RNPs and xrcc6-targeting PMO resulted in a nearly two-fold
increase in knock-in efficiency. For the ush2a C771F variant, two out of four replicates
showed a marked decrease in knock-in efficiency upon addition of the xrcc6-targeting
PMO to the injection mixture. For the tp53, co-delivery of the xrcc6-targeting PMO led
to nearly two-fold increase in knock-in efficiency in one replicate, but had little effect
in the replicate injection. To compare the effect of the xrcc6-targeting PMO on knock-in
efficiency in an unbiased manner, and limit the influence of experimenter biases, skill and
timing of injections as much as possible, all conditions with and without addition of PMO
were injected by the same experimenter in one-cell-stage embryos from the same clutch.
Injections for each target were furthermore conducted by different, skilled researchers, and
the order of injections (with or without xrcc6-targeting PMO) was randomized between
replications. Despite this careful approach, the gain in knock-in efficiency after co-injection
of the xrcc6-targeting PMO is variable and appears to differ between targets.
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increased the percentage of knock-in reads only for the ripor2 del12 variant (Figure 3B). 
Since we observed a high variation in knock-in efficiency between the different replicate 
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RNP injection ixtures results in alterative xrcc6 splicing. Both intron retention and exon 2-skipping are observed upon
RT-PCR analysis of the xrcc6 transcript in PMO-injected embryos, but not control injected embryos. Replicate injections
of C711F RNPs provide insight in variability of PMO-induced alterative xrcc6 splicing. (B) Quantification of knock-in
efficiency after sgRNA-Cas9 RNP and template injection with and without co-injection of the xrcc6-targeting PMO. For
ripor2, possibly tp53, but not ush2a, an increase in knock-in events is observed after co-injection of sgRNA-Cas9 RNPs,
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embryos of the same clutch of ggs. For ush2a C771F RNPs, addition of the PMO to the injection mixture l ads to variable
outcomes in knock-in efficiency between the replicate injections. Three out of the four replicate injections of ripor2 del12
RNPs with xrcc6-tarageting PMO display a higher knock-in efficiency, while for tp53 the addition of the PMO leads to an
increase in knock-in efficiency in one of the two replicate injections.
2.4. Correlation between Somatic Knock-In Efficiency Shortly after Injection, and Germline
Transmission in Adult Zebrafish
To establish stable knock-in zebrafish lines, it is of key importance that the mutations
identified in injected zebrafish embryos have also occurred in the germline of the zebrafish.
To increase the chances of successfully identifying injected adult fish with the variant of
interest in the germline, and limit the number of potential founder fish to be screened, a
high somatic knock-in efficiency is advantageous. Injecting very early in the zebrafish
zygote can, in theory, lead to a complete somatic knock-in embryo. In practice, this is
virtually impossible.
We screened injected adults for the presence of the variant of interest in their germline
by breeding them with wildtypes, and analyzing the DNA of their offspring, to shed light
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on the correlation between somatic knock-in efficiency and the percentage of founder
fish. For the ush2a C771F variant, we screened 10 potential founders, and identified
germline transmission of the in C771F variant in 3 of them (Table 1). We identified germline
transmission of the 12 bp deletion in ripor2 in 5 out of 11 injected adults that we screened.
These adults were raised from injected embryos in which we identified the ush2a C771F
variant and ripor2 del12 variant in respectively 3.4% and 8.6% of reads (Table 1), indicating
that somatic knock-in efficiencies in >3% of reads allow for swift identification of founders.
Note that all values on germline transmission include both knock-in events with and
without in cis knock-in of the PAM site variant, as our objective was to develop knock-in
zebrafish lines for the patient-specific variants in USH2A and RIPOR2. Stable knock-in
lines were established from ush2a C771F and ripor2 del12 founder fish. Genomic lesions
were not identified at the predicted off-target sites in the F1 fish from which we established
the stable ush2a C771F line (Reurink et al., in prep.).
Table 1. Somatic knock-in efficiency and subsequent germline transmission.





ush2a C771F 3.4% 10 3 (30%) 1 (10%)
ripor2 del12 8.6% 11 5 (45%) 2 (18%)
3. Discussion
We here present our efficient approach to develop knock-in zebrafish models to model
human disorders, illustrated for two pathogenic variants that were identified in patients
with hereditary sensory deficits. Our method combines previously described advantages
of Cas9-gRNA ribonucleoprotein (RNP) complex delivery [21], and antisense asymmetric
DNA oligo knock-in templates [4]. With this method, we observed correct knock-in of
the variant of interest in 3.4–18.0% of sequencing reads in DNA extracted from injected
embryos. We furthermore show that this approach is also highly efficient to knock-in
a small in-frame deletion, which to the best of our knowledge was not shown before.
Knockdown of Ku70 further increased knock-in efficiency for the 12-nt deletion. Raising
embryos with somatic knock-in mutations in 3–8% of sequencing reads lead to germline
transmission of the variant of interest for 30–45% of the injected larvae. The detailed
technical and procedural insights of this study, summarized in Figure 4, provide a valuable
framework for the efficient development of knock-in zebrafish models. Phenotypic analyses
of the established genetic zebrafish models are ongoing.
For a long time, modeling of human inherited disorders in zebrafish relied on the
use of loss-of-function mutations that were obtained from forward genetic screenings, and
more recently from CRISPR-Cas9-mediated genome editing [22–24]. However, with the
large variation in disease-associated genetic variants and genetic disease mechanisms, the
ability to introduce patient- or disease-specific variants in the zebrafish genome becomes
increasingly important. When modeling disease-associated variants, there is little to
no flexibility in design of the CRISPR-Cas9 strategy. Assessing and optimizing knock-
in efficiency based on introduced restriction sites or phenotypic changes, often used in
CRISPR-Cas9 optimization studies, is not an option when modeling human diseases.
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Figure 4. Proposed strategy for the efficient generation of knock-in zebrafish. Step 1 entails the
verification of sgRNA-Cas9 efficiency at creating genomic lesions using high resolution melting
(HRM) analysis. Step 2 concerns the injection of sgRNA-Cas9 ribonucleoprotein complexes and
the asy metric tisense oligonucleotide template with the variant of interest. Next generation
sequencing (NGS) is recommended to determine knock-in fficien y. I the situation of low knock-in
efficiency, k ockdown of non-hom logous end-joinin protein Ku70 (by co-delivery of an morpholino
antisense olig nucleotide (PMO), targeting xrcc6) may offer a means to improve knock-in efficiency.
Finally, injected embryos with sufficient knock-in reads can be raised to adults and screened for
founders with the variant of interest in the germline (step 3). The white boxes in step 1 and step 2
described the key components injected into the zebrafish zygote. A detailed protocol can be found in
Supplemental Document S1.
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The possibility of introducing variants of interest strongly correlates with the ability
to direct Cas9 to cleave the DNA in close proximity to the target nucleotide(s) [7]. The
ability of cleavage close to the target nucleotide is largely determined by the requirement
of Cas9 for a specific protospacer adjacent motif (PAM): NGG. Especially when relying on
commercially available CRISPR-associated proteins for RNP injection, it is not yet possible
to exploit the growing catalog of nucleases with different PAM site preferences [25]. By
chance, the design of the guide RNAs to knock in the 12-nucleotide deletion in ripor2 was
easy, as the target region contains two NGG triplets within the deletion region, and NGG
triplets immediately upstream and downstream of the intended deletion. The situation
was more complicated for the introduction of the c.2312G>T (p.(C771F)) variant in ush2a, as
few NGG triplets were available in close proximity of the target variant. The most suitable
option was a sgRNA with predicted off-target effects. All three predicted off-target sites had
multiple mismatches with the sgRNA, which we considered an acceptable tradeoff since
the use of alternative sgRNAs was expected to significantly decrease knock-in efficiency.
We indeed obtained an F1 fish with the c.2312G>T variant, and no detectible off-target
effects, from which we were able to generate a stable knock-in line in which we can assess
the molecular and functional consequences of the variant. The targeting dilemma of the
ush2a c.2312G>T variant perfectly reflects the limitations that can be encountered when
introducing disease-associated variants in the zebrafish genome, and remains a challenge
for the routine generation of zebrafish knock-in models to assess the pathogenicity of newly
identified genetic variants in the context of genetic diagnostics.
The efficient introduction of genetic variants by homology-directed repair (HDR)
strongly depends on the efficiency of sgRNA-directed cleavage of target DNA by Cas9.
While the available algorithms for sgRNA design are generally very accurate at predicting
sgRNA efficiency, it is advisable to assess this prior to investigating potential knock-in
events. While many studies employ T7 Endonuclease digestions or Next-Generation
Sequencing (NGS) to determine RNP efficiency [4,21], we prefer to assess RNP efficiency by
using High Resolution Melting (HRM) analysis [19]. This is a quick and effective method
to visualize Cas9-induced mutations (insertions and deletions) via the typical heteroduplex
signatures in the melting pattern of a PCR product. In our experience, efficient sgRNAs can
introduce heteroduplex signatures in 70–100% of RNP-injected embryos. Although in-vitro
transcribed sgRNAs were used for the RNP injections of the current study, we recently
switched to commercially produced sgRNAs as they have become more cost-effective.
For both addressed variants, we were able to continue the development of the knock-in
zebrafish with highly efficient RNPs according to these criteria. We opted to combine two
previously published improvements in zebrafish CRISPR technology, the use of sgRNA-
Cas9 RNP complexes, and antisense asymmetric knock-in template oligos [4,21]. After the
injection of both ush2a and ripor2 sgRNA-Cas9 RNP complexes and corresponding template
oligos, we observed on average less than 20% of wildtype reads in the genomic DNA of
pools of injected embryos, confirming the high genome-editing efficacy of RNP delivery in
zebrafish embryos. We furthermore identified over 5% and 12% of correct knock-in reads
of respectively the ush2a c.2312G>T and ripor2 del12 variant. These values are relatively
high compared to other studies employing short, single stranded oligonucleotide templates
(e.g., 1.92% in [4] and 2–4% in [4,26]). Especially when considering the fact that we
introduced disease-specific variants, and encountered some limitations in sgRNA design
for the introduction of the p.Cys771Phe variant in zebrafish usherin. To provide more
perspective, we also injected the tp53 sgRNA-Cas9 RNPs and R217H knock-in template
that was previously described by Prykhozhij et al., and observed lower percentages of
wildtype reads, and higher percentages of correct knock-in reads, as compared to their
publication in which Cas9 mRNA was used [4].
During the course of our studies, Bai and colleagues published that long single
strand oligonucleotide templates can provide similar values of knock-in efficiency as we
obtained here [27]. It is important to note that these long single strand oligonucleotides are
indeed longer than our antisense asymmetric oligos, but still far shorter than the (circular)
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double-stranded templates previously employed by us and others [3,15,28]. In addition,
Bai et al. first identified a highly efficient sgRNA-Cas9 combination to develop disrupt
a pigmentation-associated gene, which they later repaired by HDR, and therefore this
study may not reflect the sequence-dependent challenges encountered with introducing
disease-associated variants.
One of the few studies that do describe the generation of knock-in zebrafish models
to study the effect of disease-associated genetic variants makes use of symmetric oligonu-
cleotide templates. While no data is provided on somatic knock-in efficiency, this approach
does appear effective as germline transmission is found in 4–21% of injected zebrafish [5].
While many publications address the improvement of somatic knock-in efficiency in in-
jected embryos, the chances of identifying founder fish that pass the variant of interest to
their progeny is the most important factor for the swift development of knock-in zebrafish
models. In this respect, the aforementioned study already offers useful germline trans-
mission values. With our approach, we identified germline transmission of the variant
of interest in 30% (ush2a) and 45% (ripor2) of injected adults, whereas somatic knock-in
variants were identified in respectively 3.4% and 8.6% of sequences reads obtained from
a subset of embryos from these specific injection rounds. With these particularly high
germline transmission values obtained in this study, only few potential founder fish have
to be screened, and raising high numbers of injected embryos appears unnecessary. Both
the efficiency and timing of genome-editing are likely to be major factors in the chances of
introducing the variant of interest in the germline. Although more studies are needed to
strengthen the correlation between somatic knock-in efficiency and germline transmission
of the variant of interest, our study provides some initial insight in this relationship.
The HDR and non-homologous end-joining (NHEJ) pathway are competitive DNA
repair processes, and different approaches to shift the balance towards HDR have been
tested in various species [29]. It was previously shown that the zebrafish Ku70 protein plays
an important role in the repair of double strand DNA breaks [13]. We previously suggested
that lowering the NHEJ pathway via PMO-induced knockdown of Ku70 expression could
improve knock-in efficiency of the variants of interest [15]. Although addition of the
xrcc6-targeting PMO to the ripor2 del12 RNP/template mixture induced a two-fold increase
correct knock-in events in three out of four batches of injected embryos, the effect of the
xrcc6-targeting PMO was not consistent for all targets. We observed in increased knock-in
efficiency for only two out of six replicate injections of the ush2a C771F and tp53 R217H
targets combined. Possibly, PMO-induced repression of Ku70 expression may be more
effective in the generation of small deletions such as the ripor2 del12 variant than for
nucleotide substitutions. Due to the very early moment in zebrafish development at which
we aim to lower the NHEJ pathway, it was not possible the determine if Ku70 protein
levels and the activity of the NHEJ pathway were indeed decreased. Additionally, our
splice-modulation PMO may leave some maternally contributed xrcc6 transcripts intact.
Hence, a translation-blocking PMO could more clearly improve HDR efficiency, but this
its functionality more difficult to assess after microinjection than a splice-modulation
PMO. While aberrant splicing of the Ku70-encoding xrcc6 gene was confirmed for embryos
sampled from all injections included in the analysis, the level of aberrant splicing was
variable. It is also interesting to speculate on the effect of Ku70 knockdown on off-target
genome editing. In theory, increasing the HDR pathway will also increase the chances that
an off-target lesion is repaired based on the second allele, rather than via the NHEJ pathway.
However, investigating the effect of Ku70 knockdown on off-target lesions is premature.
We currently do not know how much knockdown of Ku70 expression is needed to drive the
repair of Cas9-induced DNA lesions towards HDR, and whether the variable effect of the
xrcc6-targeting PMO is mainly a dosage issue. In case of low somatic knock-in events—e.g.,
in <2% of sequencing reads obtained from a pool of injected embryos—it is worthwhile to
investigate if co-delivery of the xrcc6-targeting PMO with the CRISPR-mixture can increase
knock-in efficiency for that particular target. Especially since we show the chances of
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identifying founder fish are very favorable with a somatic knock-in efficiency of >3% of
sequencing reads.
Despite our best effort to rule out all bias in this study, timing of the injection of the
first cell of the zebrafish embryo may play a significant role in the knock-in efficiency.
The earlier the sgRNA-Cas9 RNP complexes and template are present in the first cell of
the zebrafish embryo, the higher the chances of knock-in events before the first DNA
replication. While we aim to start RNP injections in the zygotic zebrafish cell within 15 min
after parental zebrafish are placed together to produce eggs, the actual starting moment of
injections remains difficult to standardize.
We aim to establish knock-in zebrafish models for the patient-specific target variants,
and the PAM-site variants are just a means to reduce the chances of Cas9 re-cleaving
a knock-in allele [5]. For both ush2a C771F and tp53 R217H RNP injected larvae, the
majority of correct reads did contain the PAM site variant. The knock-in alleles without
PAM site variant likely result from crossover during homology directed repair [14]. This
notion is confirmed by the fact that we also observed sequencing reads with the PAM site
variant, but not the variant of interest. Sequencing of genomic DNA from ripor2 del12
RNP injected larvae did not provide any indication that the 12-nucleotide deletion resulted
from the injection of the RNPs alone. Despite the silent nature of the introduced PAM
site variants, we prefer knock-in zebrafish without the additional PAM-site variant as
disease models. Although unlikely, the PAM site variant may introduce a rare codon
that may alter translational efficiency of the target gene or pre-mRNA [30]. Especially for
the development of zebrafish models with gain-of-function alleles, or studies aimed to
elucidate the pathogenicity of a variant of unknown significant (VUS) identified in genetic
diagnostics, this risk is best avoided it is remains virtually impossible to determine if these
variants have any (cis) modifying effects on the gene of interest.
In conclusion, our use of sgRNA-Cas9 RNP complex injections, combined with anti-
sense asymmetric template oligos, allows for a highly efficient knock-in of genetic variants
associated with human diseases. We show that this approach is successful for both point
mutations and small in-frame deletions. Likely, our approach will also be successful to
introduce shorter and slightly larger genomic deletions. We recently also published as
strategy using 2 sgRNA-Cas9 RNP complexes to introduce larger deletions in the zebrafish
genome, such as entire exons [31]. Our approach for the introduction of nucleotide substi-
tutions and small, in-frame deletions is summarized in Figure 4, where we provide our
recommended criteria to assess RNP efficiency and knock-in efficiency to maximize the
chances of identifying founder fish with minimal screening efforts. To easily replicate our
strategy in other labs, we have included a detailed technical procedure in the Supplemental
Data (Document S1).
The majority of novel diseases-associated variants that are nowadays identified, are
found in isolated cases or families. As such, modeling the functional effects of these
variants in animal models is of key importance to provide these patients with a genetic
diagnosis. We envision that our step-by-step description will enable the more frequent use
of zebrafish to assess the pathogenicity genetic variants associated with inherited disorders,
and the molecular mechanisms underlying these disorders. The ush2a C771F and ripor2
del12 zebrafish lines will indeed be used to determine respectively the pathogenicity and
the pathogenic mechanisms of these variants in ongoing studies.
4. Materials and Methods
4.1. Zebrafish Husbandry
Wild-type Tüpfel long fin zebrafish were bred and raised under standard condi-
tions [32]. Both adult and larval zebrafish were kept at a light–dark regime of 14 h light:
10 h darkness. Adult zebrafish were fed twice daily with Gemma Micro (Skretting, Tooele,
UT, USA) and live brine shrimp. All experiments were carried out in accordance with Euro-
pean guidelines on animal experiments (2010/63/EU). Zebrafish eggs were obtained from
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natural spawning and reared at 28.5 ◦C in E3 embryo medium (5 mM NaCl, 0.17 mM KCl,
0.33 mM CaCl2, and 0.33 mM MgSO4), supplemented with 0.1% methylene blue.
4.2. sgRNA Synthesis
Design of the sgRNAs was done using CRISPRscan (https://www.crisprscan.org
(accessed on 29 November 2018)) and CHOPCHOP (https://chopchop.cbu.uib.no
(accessed on 29 November 2018)) webtools with settings for Cas9 and the in-vitro T7 pro-
motor. The sgRNAs were ordered as single stranded DNA oligonucleotides as previously
described by Gagnon et al. [24], with the addition of 5′-CCGCTAGC-3′ to the target specific
oligonucleotide to clamp the 5′end. Sequences are provided in Table S1. Target-specific and
constant oligonucleotides were annealed and complemented using Phusion High-Fidelity
DNA Polymerase (#M0530S, New England BioLabs, Ipswich, MA, USA). The reaction mix-
ture, containing 5 µM of each oligonucleotide, 0.2 mM dNTPs, 1× Phusion HF buffer and
10 units/mL Phusion polymerase, was incubated sequentially for 2 min at 98 ◦C, 10 min at
50 ◦C, and 10 min at 72 ◦C. Annealed sgRNA templates were purified using the GenElute
PCR clean-up kit (#NA1020, Sigma-Aldrich, Amsterdam, The Netherlands) according
to manufacturer’s instructions. Synthesis of sgRNAs was done using the MEGAshort-
script™ T7 Transcription Kit (#AM1354, Invitrogen, Waltham, MA, USA) according to
manufacturer’s instruction, using 200–400 ng of sgRNA template and overnight incubation
at 37 ◦C. Finally, sgRNAs were purified using the MEGAclear™ Transcription Clean-Up
Kit (#AM1908, Invitrogen, Waltham, MA, USA) according to manufacturer’s instructions,
aliquoted and stored at −80 ◦C until use.
4.3. HDR Template Design
The asymmetric antisense oligonucleotide templates are comprised of a 90-nucleotide
arm and a 36-nucleotide arm calculated from the Cas9 cleavage position. The short arm
is complementary to the sequence upstream of the Cas9 cleavage position, the long arm
complementary to the downstream region. Note that the sgRNA-Cas9 RNP complex can
target either DNA strand, and cleavage position is always determined as 3–4 nucleotides
upstream of the PAM site (NGG for S.p.Cas9). Variants of interest were introduced in
the short arm, PAM site variants in the long arm. The 12-nt deletion ripor2 template was
designed by removing these specific 12 nucleotide from the template, effectively reducing
the length of the short arm.
4.4. Zebrafish Embryo Microinjections
Injection mixtures containing 800 ng/µL Alt-R® S.p.Cas9 Nuclease V3 (Integrated
DNA Technologies, Coralville, IA, USA) sgRNA, 300 mM KCl and 20% (v/v) of phenol
red solution (#P0290, Sigma Aldrich, Amsterdam, The Netherlands) were incubated for
5 min at 37 ◦C to allow sgRNA-Cas9 ribonucleoprotein complex formation. Final concen-
trations of sgRNA in the injection mixture were 81 ng/µL (ripor2), 90 ng/µL (ush2a), and
150 ng/µL (tp53). Subsequently, 1 nL of mixture was injected into zebrafish zygotes as
previously described [33]. Single-stranded antisense asymmetric DNA oligonucleotide
templates (Table S1) containing the variants of interest were ordered from Integrated DNA
technologies, and added to the injection mixtures at a final concentration of 1 µM. xrcc6
splice-modulation morpholino oligonucleotide was purchased from Gene-Tools (Philomath,
OR, USA) and added to the mixture at a final concentration of 1.5 ng/µL as previously
described [15]. All injections were performed for >80 zygotes per condition, and only
embryos with >80% survival in injected and uninjected conditions were included for
subsequent analyses.
4.5. High-Resolution Melting Analysis
Injected and uninjected zebrafish embryos were collected individually at 1 dpf in
25 uL hotshot lysis buffer (25 mM NaOH, 0.2 mM EDTA), incubated at 95 ◦C for 20 min,
and neutralized with 2.5µL 1 M Tris pH 8. Obtained embryo lysates were diluted 5–10×
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and used as input for high-resolution melting (HRM) analysis. HRM PCR was performed in
a Quantstudio 3 Real-Time PCR System (Applied Biosystems, Waltham, MA, USA), using
Phusion High-Fidelity DNA Polymerase (#M0530S, New England Biolabs, Ipswich, MA,
USA) and 1× EvaGreen Dye (#31000, Biotium, Fremont, CA, USA). After PCR amplification,
the HRM procedure was initiated by incubating the reaction at 95 ◦C for 1 min, followed
by rapid cooling (4 ◦C/s) to 10 ◦C and a standard melt curve procedure (0.1 ◦C/s) during
which data was collected. Primer sequences are provided in Table S1.
4.6. Ion Torrent Sequencing and Analysis
DNA was extracted from pools of 20–25 sgRNA-Cas9 RNP complex-injected 1 dpf
zebrafish embryos, or offspring from potential founder fish, using the QIAamp DNA
Mini Kit (#51304, QIAGEN, Hilden, Germany). PCR products for Ion Torrent sequencing
were prepared using Q5 High-Fidelity polymerase (#M0491L, New England BioLabs,
Ipswich, MA, USA) and target-specific primers with or without barcodes for multiplex
sequencing (Table S1). PCR products from individual biological samples were amplified
using different indexed primers and then pooled in equimolar amounts into sequencing
samples. Barcoding was not used in the initial experiments where unique amplicons were
pooled. The obtained sequencing reads were demultiplexed, mapped against wildtype
specific Fasta files, and analyzed for knock-in events using the SEQNEXT software (JSI
Medical Systems, Ettenheim, Germany). The percentage of knock-in reads was calculated
by filtering reads to contain the knock-in events and correct flanking sequence for 20 bp
up- and downstream of the variants of interest. The obtained sequencing reads contained
an occasional mismatch with the reference sequence, but in light of the very low frequency
of these variants (>0.01 of reads), known error rate of the Ion Torrent System, and distance
to the Cas9 cleavage site, additional filtering was not applied.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10.3
390/ijms22179429/s1, Figure S1: (A) Sequence alignment of the amino acids encoded by human
and zebrafish USH2A exon 13 reveals a high conservation at both the amino acid level, and the
EGF-laminin protein domain architecture. Conserved cysteines that form the disulphide bonds in the
EGF-laminin domains are indicated in green. The frequently mutated cysteine at position p.759 of
human usherin, and orthologous cysteine of zebrafish usherin, are indicated in red. (B) Sequence
alignment of the amino acids encoded by human and zebrafish RIPOR2 target region in exon 14. The
amino acids corresponding to human RIPOR2 p.(Gln566_Lys569del) are indicated in red, Table S1:
list of oligonucleotide sequences.
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